Elinzanetant for treating vasomotor symptoms caused by adjuvant endocrine treatment to prevent or treat hormone-receptor positive breast cancer [ID6544]

  • Awaiting development
  • GID-TA11784
  • Expected publication date: TBC

Documents

Documents created during the development process.

Notes